BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24574317)

  • 21. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of Epstein-Barr virus DNA levels in peripheral blood samples of Italian patients with undifferentiated carcinoma of nasopharyngeal type.
    Bortolin MT; Pratesi C; Dolcetti R; Bidoli E; Vaccher E; Zanussi S; Tedeschi R; De Paoli P
    Cancer Lett; 2006 Feb; 233(2):247-54. PubMed ID: 15907367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA.
    Hong RL; Lin CY; Ting LL; Ko JY; Hsu MM
    Cancer; 2004 Apr; 100(7):1429-37. PubMed ID: 15042677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D; Srivatanakul P; Karalak A; Ishida T
    J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans-oral brush biopsies and quantitative PCR for EBV DNA detection and screening of nasopharyngeal carcinoma.
    Ng RH; Ngan R; Wei WI; Gullane PJ; Phillips J
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):602-9. PubMed ID: 24486777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical applications of plasma Epstein-Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein-Barr virus DNA.
    Chan KC; Lo YM
    Methods Mol Biol; 2006; 336():111-21. PubMed ID: 16916257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
    Niemhom S; Maeda S; Raksakait K; Petchclai B
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
    Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
    Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
    J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
    Tsai ST; Jin YT; Mann RB; Ambinder RF
    Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assay of Epstein-Barr virus in nasopharyngeal tissues and serum of patients with nasopharyngeal carcinoma].
    Li XM; Yang CZ; Chen PJ; Su ZL; Song Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Sep; 14(9):400-1. PubMed ID: 12563909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
    Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY
    Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of Epstein-Barr virus in nasopharynx tissue and desquamatine cell for diagnosis of nasopharyngeal carcinoma].
    Sun Z; Xiao C; Jiang W; Feng X; Liu Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(4):153-4. PubMed ID: 16711437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine.
    Sengar M; Chorghe S; Jadhav K; Singh S; Laskar SG; Pai P; Aggarwal JP; D'Cruz A; Chaturvedi P; Deshpande M; Chaukar D; Budrukkar A; Gupta T; Murthy V; Kane S; Thakur M; Rangarajan V; Kannan S; Shet T; Kode J
    Head Neck; 2016 Apr; 38 Suppl 1():E1666-73. PubMed ID: 26667883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of Epstein-Barr virus DNA in desquamative cell of nasopharyngeal carcinoma by polymerase chain reaction].
    Chen W; Chen Y; Ji C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(6):327-9. PubMed ID: 7742020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study.
    Mäkitie AA; Reis PP; Irish J; Zhang T; Chin SF; Chen X; Marriott C; Keller A; Perez-Ordonez B; Kamel-Reid S; Siu LL
    Head Neck; 2004 Sep; 26(9):815-22. PubMed ID: 15350028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
    Lo YM; Chan LY; Lo KW; Leung SF; Zhang J; Chan AT; Lee JC; Hjelm NM; Johnson PJ; Huang DP
    Cancer Res; 1999 Mar; 59(6):1188-91. PubMed ID: 10096545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
    Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
    Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.